In the first order, I think I've talked clearly about the things that really worry me about this bill. I spoke very forcefully about that because I need it to be heard. This is a real danger.
In the second order, on conversations around the management of things like nicotine replacement therapies, which don't have tobacco, using an act that's really for tobacco and vaping.... I'm willing to have that conversation. I understand your objective, but I would ask, what about the precision regulatory ability to go after pseudoephedrine, which is a precursor to methamphetamine? We need to have the ability writ large to act in an agile way to an ever-evolving environment. Unfortunately, in the manufacturing of illicit drugs, for example, a lot of things that can seem very innocuous can suddenly be used in very dangerous ways. Maintaining that precision regulatory power is something that is very important to protect the country, but I would say to your other point.... Every conversation you and I have had, Luc, has been centred in very reasonable positions.
I apologize for speaking in English, but things like “pseudoephedrine” and “precursors to methamphetamine” are not words I'd say well in French.